Altimmune, Inc. (ALT) Shareholders’ equity 2016–2025
Altimmune, Inc. (ALT) shareholders’ equity at each fiscal year-end, per SEC filings.
$224.9MFY2025 · since FY2016: $32.2M → $224.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $224.9M | +82.1% |
| FY2024 | $123.5M | -36.4% |
| FY2023 | $194.1M | +4.8% |
| FY2022 | $185.3M | -7.0% |
| FY2021 | $199.1M | -11.8% |
| FY2020 | $225.9M | +396.2% |
| FY2019 | $45.5M | -5.8% |
| FY2018 | $48.3M | +22.6% |
| FY2017 | $39.4M | +22.3% |
| FY2016 | $32.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice